Literature DB >> 21726701

Epidemiology of lung cancer.

Aoife McErlean1, Michelle S Ginsberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21726701     DOI： 10.1053/j.ro.2011.02.002

Source DB:  PubMed          Journal:  Semin Roentgenol        ISSN： 0037-198X            Impact factor:   0.800


× No keyword cloud information.
  23 in total

1.  lncRNA-HIT promotes cell proliferation of non-small cell lung cancer by association with E2F1.

Authors:  L Yu; F Fang; S Lu; X Li; Y Yang; Z Wang
Journal:  Cancer Gene Ther       Date:  2017-04-21       Impact factor: 5.987

2.  No significant association between the XRCC3 Thr241Met polymorphism and lung cancer risk: a meta-analysis.

Authors:  Yun-Hua Xu; Lin-Ping Gu; Ying-Jia Sun; Bai-Jun Cheng; Shun Lu
Journal:  Tumour Biol       Date:  2013-01-09

3.  Temporal trends in demographics and overall survival of non-small-cell lung cancer patients at Moffitt Cancer Center from 1986 to 2008.

Authors:  Matthew B Schabath; Zachary J Thompson; Jhanelle E Gray
Journal:  Cancer Control       Date:  2014-01       Impact factor: 3.302

4.  TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancer.

Authors:  Matthew B Schabath; Anna R Giuliano; Zachary J Thompson; Ernest K Amankwah; Jhanelle E Gray; David A Fenstermacher; Kristen A Jonathan; Amer A Beg; Eric B Haura
Journal:  Carcinogenesis       Date:  2013-07-09       Impact factor: 4.944

5.  Association between the XRCC3 C241T polymorphism and lung cancer risk in the Asian population.

Authors:  Xin Tian; Ye Tian; Ping Ma; Chengguang Sui; Fandong Meng; Yan Li; Liye Fu; Tao Jiang; Yang Wang; Youhong Jiang
Journal:  Tumour Biol       Date:  2013-06-08

6.  Interleukin polymorphisms associated with overall survival, disease-free survival, and recurrence in non-small cell lung cancer patients.

Authors:  Nicholas T Woods; Alvaro N Monteiro; Zachary J Thompson; Ernest K Amankwah; Nina Naas; Eric B Haura; Amer A Beg; Matthew B Schabath
Journal:  Mol Carcinog       Date:  2015-01-18       Impact factor: 4.784

7.  P53 codon 72 polymorphism and lung cancer risk: evidence from 27,958 subjects.

Authors:  Chao Zhou; Hao Chen; An Wang
Journal:  Tumour Biol       Date:  2013-05-30

Review 8.  Current and future targeted therapies for non-small-cell lung cancers with aberrant EGF receptors.

Authors:  Shanthi Kanthala; Sandeep Pallerla; Seetharama Jois
Journal:  Future Oncol       Date:  2015       Impact factor: 3.404

Review 9.  Advanced bronchoscopic techniques in diagnosis and staging of lung cancer.

Authors:  Bojan Zaric; Vladimir Stojsic; Tatjana Sarcev; Goran Stojanovic; Vladimir Carapic; Branislav Perin; Paul Zarogoulidis; Kaid Darwiche; Kosmas Tsakiridis; Ilias Karapantzos; Georgios Kesisis; Ioanna Kougioumtzi; Nikolaos Katsikogiannis; Nikolaos Machairiotis; Aikaterini Stylianaki; Christophoros N Foroulis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2013-09       Impact factor: 2.895

10.  Alveolar type II cells possess the capability of initiating lung tumor development.

Authors:  Chuwen Lin; Hai Song; Cecilia Huang; Erica Yao; Rhodora Gacayan; Shan-Mei Xu; Pao-Tien Chuang
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.